A Systematic Approach to Design and Prepare Poly(meth)acrylate Based Solid Dispersions of Poorly Water-soluble Drug by Spray Drying

References

• Albers, J., R. Alles., K. Matthee., K. Knop., J. H. Nahrup, and P. Kleinebudde. 2009. Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusion. European Journal of Pharmaceutics and Biopharmaceutics 71:387–394.
   PubMed Web of Science ®Google Scholar
• Alhnan, M. A., E. Kidia., and A. W. Basit. 2011. Spray-drying enteric polymers from aqueous solutions: a novel, economic, and environmentally friendly approach to produce pH-responsive microparticles. Europian Journal of Pharmaceutics and Biopharmaceutics 79:432–439.
   PubMed Web of Science ®Google Scholar
• Ambrogi, V., L. Perioli., C. Pagano., and F. Marmottini. 2012. Use of SBA-15 for furosemide oral delivery enhancement. European Journal of Pharmaceutics and Biopharmaceutics 46:43–48.
   Web of Science ®Google Scholar
• Ambrogi, V., L. Perioli., C. Pagano., and L. Latterini. 2012. MCM-41 for furosemide dissolution improvement. Microporous and Mesoporous Materials 147:343–349.
   Web of Science ®Google Scholar
• Devarakonda, B., D. P. Otto, A. Judefeind, and R. A. Hill. 2007. Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes. International Journal of Pharmaceutics 345:142–153.
   PubMed Web of Science ®Google Scholar
• Dhirendra, K., S. Lewis., N. Udupa., and K. Atin. 2009. Solid dispersions: A review. Pakistan Journal of Pharmaceutical Science 22:234–246.
   PubMed Web of Science ®Google Scholar
• Duarte, I., M. Temtem., M. Gil., and F. Gaspar. 2011. Overcoming poor bioavailability through amorphous solid dispersions. Industrial Pharmacy 30:4–6.
   Google Scholar
• Kanyak, M. S., and S. Sahin. 2013. Development and validation of RP HPLC method for determination of solubility of furosemide. Turkish Journal of Pharmaceutical Science 10:25–34.
   Google Scholar
• Kojima, Y., T. Ohta., K. Shiraki., R. Takano., H. Maeda., and Y. Ogawa. 2013. Effects of spray drying process parameters on the solubility behavior and physical stability of solid dispersions prepared using a laboratory-scale spray dryer. Drug Development and Industrial Pharmacy 39:1484–1493.
   PubMed Web of Science ®Google Scholar
• Laulicht, B., A. Tripathi., and E. Mathiowitz. 2011. Diuretic bioactivity optimization of furosemide in rats. European Journal of Pharmaceutics and Biopharmaceutics 79:314–319.
   PubMed Web of Science ®Google Scholar
• Mohanachandran, P. S., P. G. Sindhumol., and T. S. Kiran. 2010. Enhancement of solubility and dissolution rate: An overview. International Journal of Comprehensive Pharmacy 4:1–10.
   Google Scholar
• Nollenberger, K., A. Gryczke, T. Morita., and T. Ishii. 2009. Using polymers to enhance solubility of poorly soluble drugs. Pharmaceutical Technology S2–S6. http://www.pharmtech.com/using-polymers-enhance-solubility-poorly-soluble-drugs
   Google Scholar
• Padden, B. E., M. Millar, T. Robbins., P. D. Zocharski, L. Prasad, J. K. Spence., and J. LaFountaine. 2011. Amorphous solid dispersions as enabling formulations for discovery and early development. American Pharmaceutical Review. http://www.americanpharmaceuticalreview.com/Featured-Articles/37035-Amorphous-Solid-Dispersions-as-Enabling-Formulations-for-Discovery-and-Early-Development/
   Google Scholar
• Patel, B. B., J. K. Patel., S. Chakraborty., and D. Shukla. 2013. Revealing facts behind spray dried solid dispersion technology used for solubility enhancement. Saudi Pharmaceutical Journal [In Press] 2013. doi:10.1016/j.jsps.2013.12.013
   Google Scholar
• Patel, B. B., J. K. Patel, and S. Chakraborty. 2015. Solubility enhancement using poly(meth)acrylates based solid dispersion. Powder Technology 270:27–38.
   Web of Science ®Google Scholar
• Patel, R. C., R. A. Keraliya, N. M. Patel, and M. Patel. 2010. Commonsensical predetermined dissolution time of furosemide achieve by inclusion complex. International Journal of Pharmaceutics and Pharmaceutical Science 2:142–146.
   Google Scholar
• Prandota, J., and M. Witkowska. 1976. Pharmacokinetics and metabolism of furosemide in man. European Journal of Drug Metabolism and Pharmacokinetics 4:177–181.
   Google Scholar
• Santus, G., C. Lazzarini, G. Bottoni, and E. P. Sandefer. 1997. An in-vitro in-vivo investigation of oral bioadhesive controlled release furosemide formulation. European Journal of Pharmaceutics and Biopharmaceutics 44:39–52.
   Web of Science ®Google Scholar
• Shin, S., and J. Kim. 2003. Physicochemical characterization of solid dispersion of furosemide with TPGS. International Journal of Pharmaceutics 251:79–84.
   PubMed Web of Science ®Google Scholar
• Shukla, D., S. Chakraborty., S. Singh., and B. Mishra. 2011. Lipid-based oral multiparticulate formulations - advantages, technological advances and industrial applications. Expert Opinion in Drug Delivery 8:207–224.
   PubMed Web of Science ®Google Scholar
• Six, K., G. Verreck., J. Peeters, M. Brewster., and G. Mooter. 2004. Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow- dissolving polymers. Journal of Pharmaceutical Science 93:124–131.
   PubMed Web of Science ®Google Scholar
• Teja, S. B., S. P. Patil., G. Shete., S. Patel., and A. Bansal. 2013. Drug-excipient behavior in polymeric amorphous solid dispersions. Journal of Excipients and Food Chemicals 4:70–94.
   Google Scholar
• Verma, S., A. Rawat, M. Kaul., and S. Saini. 2011. Solid dispersion: A strategy for solubility enhancement. International Journal of Pharmaceutical Technology 3:1062–1099.
   Google Scholar